Glaucoma 360, a three-day event being held here by the Glaucoma Research Foundation (GRF), will move from its "Celebrate" phase with Annual Gala on Thursday into its "Innovate" phase with the New Horizons Forum set for today. This event is a full day of presentations, panels, and discussions featuring leaders from start-up companies, industry executives, ophthalmic experts, venture capitalists, and the FDA.
Glaucoma 360, a three-day event organized by the Glaucoma Research Foundation (GRF) will move into its final day on Saturday with the Glaucoma Symposium. The focus will shift from "Innovate" to "Educate." Two continuing medical education sessions are-one for ophthalmologists in the morning and another for optometrists in the afternoon.
Mark Silverberg, MD, shares the results of a study published in JAAPOS that the correction of Amblyopia correction could lead to an increased reading speed and efficiency in school-aged kids.
Although there are no scientifically proven ways to prevent glaucoma, healthy habits–such as moderate exercise, regular visual check-ups, and eating green, leafy vegetables–represent a good starting point for a prevention strategy.
Investigations of the biomechanical changes in the optic nerve head may eventually lead to improvements in therapies for patients with glaucoma.
A portable device for detecting multifocal steady-state visual evoked potentials associated with visual field stimulation is being developed as an objective test for identifying glaucoma-related visual function loss.
I have an idea. The idea is based upon what seems to be an almost-universally accepted belief that before there should be widespread use of surgical or medical therapies to treat patients with diseases, those therapies should first be vetted in controlled clinical trials involving a limited sample of the afflicted population.
A review of glaucoma drugs in various clinical study phases reveals that at least seven new glaucoma drugs were in trials and two others were approved by the FDA in 2017. Many drugs that have progressed the most act on prostaglandin receptors, though some combine this with other mechanisms of action.
Ophthalmology Times is pleased to announce Melina I. Morkin, MD, and Pedram Hamrah, MD, FACS, of New England Eye Center/Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, as the third-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Julie Gough-Nelson shares the three important things worth remembering in an era of online reviews for best-practice management.
Blogger Donna Suter draws from personal experience and provides four tips on maintaining the needs of your practice in an evolving business climate.
The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. “Steve” Speares will serve as the society’s next executive director, according to a prepared statement.
When customizing treatment plans for glaucoma patients, selective laser trabeculoplasty (SLT) can be as useful in diagnosis as it is in reducing IOP, explains Inder Paul Singh, MD, FEBOphth.
Dr. Mali discusses how the Quarterly Questions program assesses fundamental (“walking around”) knowledge needed in the everyday practice of ophthalmology (40 questions annually), as well as the application of information from five journal articles (10 questions annually).
After decades of slow, but steady, progress in the advancement of glaucoma as a subspecialty, the last quarter century has seen tremendous innovation in this field.
The Intelligent Research in Sight (IRIS) Registry-a comprehensive eye disease registry developed by the American Academy of Ophthalmology (AAO)-has far surpassed early estimates for physician participation, according to William L. Rich III, MD, FACS.
Tomographic imaging gives surgeons a fuller view of the eye, making it easier to detect early signs of keratoconus.
A micro-interventional device that uses a nitinol filament can dissect any grade cataract without causing capsular stress.
One approach that is sometimes recommended to give honest feedback is to deliver it between two positive comments. This is known as the “compliment sandwich.” While some advocates of this approach still assert its value, it is largely out of favor and is often ridiculed.
The 2017 Charles D. Kelman Lecture touched on three main areas-from the teaching of the phaco technique during the early years of phaco to use of phaco in glaucoma patients to the introduction of phaco to surgeons in developing countries.
Customized corneal crosslinking for keratoconus focuses the treatment on the weak area of the cornea.
In a study with 10 patients, persistent infectious keratitis was successfully treated with CXL and riboflavin.
When considering the Boston type 1 keratoprosthesis as the evidence-based procedure of choice for managing cornea graft failure, superior visual outcomes must be weighed against greater risk of sight-threatening complications.
Clinicians evaluated the refractive, pachymetric, topometric, and visual rehabilitation changes with the Athens Protocol applied in patients with keratoconus. Joanna Kontari, MD, highlights some of the research findings and implications.
Ophthalmology Times is pleased to announce Igor I. Bussel, MD, MS, MHA, and Deepinder K. Dhaliwal, MD (faculty sponsor), of the Department of Ophthalmology, University of Pittsburgh/UPMC Eye Center, Pittsburgh, as the second-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.